HONOLULU Brooks Koepka hasn't been the same since he tied for third in the FedEx Cup final in August, and hasn't felt entirely healthy since last March.
He wouldn't rate himself full strength now.
Koepka returns to competition this week in the Abu Dhabi HSBC Championship, his first tournament since he reinjured his left knee in South Korea at the CJ Cup. He said Tuesday his left knee doesn't feel the same as my right.
It probably won't for a while, but it does feel stable, Koepka said. Leaving Korea and all the way up to about a month ago, it just didn't feel stable. It felt like it could either way. It could go left, out, back.
Koepka says he's had issues since March and just dealt with them. He still managed to win the PGA Championship for the second straight year and pick up his first World Golf Championship. During his short offseason, Koepka had stem cell treatment on his left knee because the patella tendon was partially torn.
Then, he was walking off a tee when he slipped on a wet piece of cement, went to brace himself from falling and reinjured the knee. He said his knee cap moved into the fat pad, which he described as excruciating.
He had physical therapy in San Diego for most of December and says he started hitting balls right before Christmas. Koepka said he wouldn't have flown to the United Arab Emirates if he didn't feel healthy, and that his speed and everything else about his game were the same as before he was hurt at the CJ Cup.
"From that moment on, after a couple days of hitting balls and not feeling pain, it was like, 'OK, I could get back here and do this and finally play,'" he said.
A NAME FROM THE PAST
The first player of note from an emerging golf nation is not always the best one. As Li Haotong of China was making his debut at the Presidents Cup, Guan Tianlang was preparing to qualify for the PGA Tour Series-China.
Guan, who won the Asia-Pacific Amateur and then made the cut at the Masters and Zurich Classic when he was 14, made it through. Despite closing with a 79, he tied for 10th last week to earn full status for the season in China.
Guan is a sophomore at Arizona and is still an amateur.
"I think I will turn pro soon," he said, adding there was a "good chance" he would play China's opening tournament. But I still need some time to think about everything. I might also balance school and play professional events.
Guan says he expected some highs and lows after his Masters performance. "I think that I'm trending in the right direction now," he said.
Graeme McDowell can add his name to the list of players who went searching for distance and lost sight of their game.
McDowell was enthusiastic at the Sony Open, and that was before he closed with rounds of 67-64 for the best weekend score at wet Waialae. It gave him a tie for fourth, his best finish since winning in the Dominican Republic last spring.
He attributes that to getting back to his normal flight with irons.
McDowell started working in August with Kevin Kirk, also the swing coach for Patrick Reed.
"The first thing I said was I've got to start hitting it lower again," McDowell said. I'm not playing the wind anymore. That was my bread and butter.
He still works with Pete Cowen, but McDowell said their schedules didn't mesh as much with McDowell out of the top 50 and not playing in all the majors or World Golf Championships.
Where did he lose his way?
"It probably came from trying to launch the drive too high in a little search for a wee bit of distance," he said. I got an iron in my hand, it was vertical. That's not me. I need to hit the ball back down to a good window.
For two weeks in the Hawaii wind, he said he was back to G-Mac style.
SHORT ROAD, LONG SHOT
For the host country of the Tokyo Olympics, Hideki Matsuyama (No. 21) and Shugo Imahira (No. 33) are the leading candidates to represent Japan.
Next in line is Ryo Ishikawa at No. 83. Ishikawa showed signs of getting back to form last year when he won three times on the Japan Golf Tour, his first titles since 2016 and his biggest year in Japan since 2010. The problem facing him now is a schedule.
Ishikawa is part of a solid field this week in the Singapore Open, co-sanctioned by Japan. Among those playing are Justin Rose, Henrik Stenson and Matt Kuchar. Otherwise, the Japan Golf Tour season doesn't start until a week after the Masters. That would leave Ishikawa only six events on his home tour before the cutoff for the Olympics.
Ishikawa is looking for sponsor exemptions, with his eye on the Genesis Invitational at Riviera and perhaps the Arnold Palmer Invitational at Bay Hill. He made his U.S. debut at Riviera in 2009 when he was 17.
Six new players were selected for the 16-member Player Advisory Council this year, the group tasked with listening to players and conveying their thoughts to the four members of the PGA Tour's policy board. The newcomers include Russell Knox and Harry Higgs.
More telling was who was put up for election as PAC chairman, who next year would join the policy board Justin Thomas, Charley Hoffman and Peter Malnati. That assures a streak that probably should have ended long ago. No foreign-born player has ever been on the policy board.
Last year, 48 of the 125 players who qualified for the FedEx Cup postseason were international players, including 12 of the 30 who reached the Tour Championship.
The others on the PAC: Ryan Armour, Paul Casey, Zach Johnson, Anirban Lahiri, Rory McIlroy, Jon Rahm and Harold Varner III all served last year. Also new for this year are David Hearn, Billy Horschel, Ryan Palmer and Kevin Streelman.
Missing from the list is Bryson DeChambeau. Last year at The Northern Trust, when he was criticized for how long it took him to play a shot, DeChambeau said, I've asked to be on the PAC committee for three years, and it takes time to get on there.
Higgs is a rookie, although the PAC is evenly populated by players young and old, high and low in the FedEx Cup.
The election for PAC Chairman ends on Feb. 7.
Collin Morikawa's three-putt from 4 feet on the final hole of the Sony Open took him from a potential four-way tie for ninth to a seven-way tie for 21st. Perhaps more than a difference of $108,900 if he had made the short birdie, Morikawa would have moved to No. 50 in the world. He's No. 53. Morikawa needs to be in the top 50 a week before the Masters to get an invitation. ... Inbee Park is returning to Australia for the first time in six years. Park, voted the LPGA Tour's best player of the last decade, plans to play the Vic Open and the Australian Ladies Masters in February. ... The last seven rounds on the PGA Tour in Hawaii were played under lift, clean and place rules.
STAT OF THE WEEK
Lanto Griffin was 7-under par on the 18th hole of the Sony Open. He played the other 68 holes in 1 under.
I think we know all four tournaments that I'm looking forward to. I think that's pretty obvious. Brooks Koepka. Four of his seven victories since 2017 have been majors.
- Therapeutic Solutions International Successfully Treats No Option Patients with its JadiCell Stem Cell Therapy While Advancing Preparations for Phase... - January 2nd, 2022
- Exclusive: Ronnie Coleman on Recent Weight Gain, Current Strength, and Health Progress - BarBend - January 2nd, 2022
- Mesenchymal stem/stromal cell-based therapies for severe viral pneumonia: therapeutic potential and challenges - DocWire News - January 2nd, 2022
- Brainstorm Cell Therapeutics (BCLI) Receives FDA Authorization for Expanded Dosing Program; Shares Higher - InvestorsObserver - January 2nd, 2022
- Cell Freezing Media for Cell Therapy Market Size 2021 Analysis by Top Companies | Biolife Solutions,Thermo Fisher Scientific,Merck,Ge Healthcare ... - January 2nd, 2022
- Stem Cell Treatment Improves Type 1 Diabetes in 1 Patient - Everyday Health - December 23rd, 2021
- Avra, Inc. Completes its Merger with Springs Rejuvenation, LLC, a Stem Cell and Anti-Aging Treatment Company - GlobeNewswire - December 23rd, 2021
- Global Regenerative Medicine Market is Expected to Reach USD 57.08 Billion by 2027, Growing at a CAGR of 11.27% Over the Forecast Period. -... - December 23rd, 2021
- Importance of stem cells-Past, present and future - Express Healthcare - December 23rd, 2021
- Stem cell therapy holds immense promise for the treatment of patients with non-healing ischemic leg wounds - Ibcworldnews - December 23rd, 2021
- BioRestorative Therapies, Inc. Releases Year-End Message - BioSpace - December 23rd, 2021
- Corneal epithelial differentiation of human pluripotent stem cells generates ABCB5+ and Np63+ cells with limbal cell characteristics and high wound... - December 23rd, 2021
- Receiving CAR-T therapy sooner improves lymphoma survival, according to study published in New England Journal of Medicine - Newswise - December 23rd, 2021
- Cell Therapy Market becoming larger and Massively Growing up with CAGR of 25.6% mainlander.nz - mainlander.nz - December 23rd, 2021
- City of Hope presents leading-edge research on blood cancer therapies and its vaccine to reduce stem cell transplant complications at American Society... - December 23rd, 2021
- This Startup Is Makingand ProgrammingHuman Cells - WIRED - December 23rd, 2021
- Daiichi Sankyo Authorizes the First YESCARTA (Axicabtagene Ciloleucel) CAR T-cell Therapy Treatment Site in Japan - Business Wire - December 23rd, 2021
- Communication between cells plays a major role in deciding their fate > News > USC Dornsife - USC Dornsife College of Letters, Arts and Sciences - December 23rd, 2021
- Emendo Biotherapeutics and Seattle Childrens Research Institute Announce Collaboration to Develop CRISPR-based Therapeutic Strategy for Severe... - December 23rd, 2021
- National Advertising Division Recommends Cryo-Cell Discontinue or Modify Certain Health-Related Claims for Cord Blood Banking and Treatment Services -... - December 23rd, 2021
- Systemic Mastocytosis Treatments Gain Hope Due To Increasing Novel Treatment Options - PRNewswire - December 23rd, 2021
- Seven tech trends to watch in 2022 | The Star - Toronto Star - December 23rd, 2021
- Seven tech trends to watch in 2022 | ThePeterboroughExaminer.com - ThePeterboroughExaminer.com - December 23rd, 2021
- Stem Cell Therapy: Alternative Treatment to Hip & Knee ... - November 22nd, 2021
- How The Overlap Between Artificial Intelligence And Stem Cell Research Is Producing Exciting Results - Forbes - November 22nd, 2021
- Selma Blair Posts Nude Diving Photo After MS Stem Cell ... - November 22nd, 2021
- Stem Cell Therapy Reduces Need for Nearly 10% of Hip Replacements - Yale School of Medicine - November 22nd, 2021
- Stem cell therapy for heart failure lowers risk of adverse outcomes - Cardiovascular Business - November 22nd, 2021
- A second HIV patient may have been 'cured' of infection without stem cell treatment, in extremely rare case - CNN - November 22nd, 2021
- The Promise of Stem Cells to Help Children with Autism - Entrepreneur - November 22nd, 2021
- Global Cell Therapy Manufacturing Market Competition Forecast & Opportunities to 2026 - ResearchAndMarkets.com - Galveston County Daily News - November 22nd, 2021
- Dr Pengyi Yang wins National Stem Cell Foundation Metcalf Prize - News - The University of Sydney - November 22nd, 2021
- BioRestorative Therapies Enters into Letter of Intent with PRC Clinical - BioSpace - November 22nd, 2021
- SC21- 21st century cellular medicines specialists - The Thaiger - November 22nd, 2021
- From asthma to cancer to infertility, the new treatments, jabs and meds making us healthier... - The Sun - November 22nd, 2021
- New hope for bowel cancer patients as fresh partnership between Carina Biotech and CellVec enables advancement of clinical trials. - Bio-IT World - November 22nd, 2021
- FDA Approves Merck's KEYTRUDA (pembrolizumab) as Adjuvant Therapy for Certain Patients With Renal Cell Carcinoma (RCC) Following Surgery - Business... - November 22nd, 2021
- Mum with brain fog and pins and needles in hands devastated by 'ticking time bomb' MS - Mirror.co.uk - November 22nd, 2021
- CAR T-cell therapy: Hear from a Canadian patient - CTV News - November 8th, 2021
- Talaris therapy ends need for immune drugs in transplant patients - - pharmaphorum - November 8th, 2021
- Treatment Sequencing Could Change With Complementary Combinations and CAR T Options in B-ALL - OncLive - November 8th, 2021
- Parkinson's gene therapy restores responses to dopamine-boosting drug in mouse models - FierceBiotech - November 8th, 2021
- Studies: CAR-T therapies superior to standard treatment in blood cancer - STAT - November 8th, 2021
- Salit Discusses the Use of Staging and Grading for Patients With GVHD to Choose Appropriate Treatment - Targeted Oncology - November 8th, 2021
- Orchard Therapeutics Reports Third Quarter 2021 Financial Results and Highlights Recent Business Updates - BioSpace - November 8th, 2021
- Global Stem Cell Therapy Market Size, Analytical Overview, Growth Factors, Demand, Trends and Forecast to 2026 - Northwest Diamond Notes - November 8th, 2021
- BioLineRx Announces an Oral Presentation and Three Poster Presentations at the 63rd American Society of Hematology (ASH) Annual Meeting &... - November 8th, 2021
- CRISPR Therapeutics Provides Business Update and Reports Third Quarter 2021 Financial Results - Yahoo Finance - November 8th, 2021
- Bacterial Infections Linked with Unapproved Stem Cell Treatments - Contagionlive.com - October 28th, 2021
- Team finds way to enhance stem cell therapy for CNS injuries - BioPharma-Reporter.com - October 28th, 2021
- Stem cell therapy can help combat common symptoms of aging - The Mountaineer - October 28th, 2021
- Stem Cells Used to Treat Avascular Necrosis of the Femoral Head - Yale School of Medicine - October 28th, 2021
- Vitti Labs Announces FDA Approval of IND Application for Phase II Clinical Trial of Combination Mesenchymal Stem Cell and Exosome Treatment of Novel... - October 28th, 2021
- Biohaven Enrolls Phase 1a/1b Clinical Trial of BHV-1100, Lead Asset from its ARM (Antibody Recruiting Molecule) Platform, in Combination with NK Cell... - October 28th, 2021
- The Power of the Immune System: New Treatment for Painful Blood Cancer Side Effect - Curetoday.com - October 28th, 2021
- Global Cell Therapy Market Research Report 2021: Opportunities with the Approval of Kymriah and Yescarta Across Various Countries -... - October 28th, 2021
- Pursuing Optimal Therapy Remains a Challenge in Indolent B-Cell Lymphoma - Targeted Oncology - October 28th, 2021
- Stem Cell Therapy Market Research Report by Cell Source, by Type, by Therapeutic Application, by End-User, by Region - Global Forecast to 2026 -... - October 16th, 2021
- Harvard's R&D alliance with Resilience to advance manufacture of complex medicines - Harvard Gazette - October 16th, 2021
- A New Line of Defense in Blood Cancer: Natural Killer Cell Therapy - Curetoday.com - October 16th, 2021
- Dr. Kahl on the Potential Utility of Frontline CAR T-Cell Therapy in MCL - OncLive - October 16th, 2021
- Rheumatoid Arthritis Stem Cell Therapy Market By Type (Allogeneic Mesenchymal Stem Cells, Bone Marrow Transplant, Adipose Tissue Stem Cells) and By... - October 16th, 2021
- Orchard Therapeutics Outlines Comprehensive Presence at the European Society of Gene & Cell Therapy Congress - Yahoo Finance - October 16th, 2021
- Taking aim at the brain, Takeda strikes up cell therapy R&D alliance with Immusoft - MedCity News - October 16th, 2021
- Dr. Erba on the Evolution of Treatment in MCL - OncLive - October 16th, 2021
- Newer Agents for DLBCL Show Potential for Earlier Use in the Course of Treatment - Targeted Oncology - October 16th, 2021
- FDA Approves Genentech's Tecentriq as Adjuvant Treatment for Certain People With Early Non-Small Cell Lung Cancer - Business Wire - October 16th, 2021
- Worldwide Cell Therapy Consumables Industry to 2031 - Featuring Bio-Techne, Irvine Scientific and Sartorius Among Others - PRNewswire - October 16th, 2021
- International ZIM Network: SmartMed - Regenerative Solutions for the Therapies of Tomorrow - Business Wire - October 16th, 2021
- BioLineRx Announces Positive Results from Pharmacoeconomic Study Positioning Motixafortide as Potential Standard of Care in Stem Cell Mobilization -... - October 16th, 2021
- FTC Follows Through On Prioritizing Investigations Into False Advertising In Healthcare Markets - Media, Telecoms, IT, Entertainment - United States -... - October 16th, 2021
- Molecular Atlas of Small Cell Lung Cancer Reveals Unusual Cell Type That Could Explain Why Its So Aggressive - On Cancer - Memorial Sloan Kettering - October 16th, 2021
- Actress Jennifer Garner Visits with 7-Year-Old Girl Fighting B-cell Acute Lymphoblastic Leukemia; What is the Treatment for This Disease? -... - October 16th, 2021
- Four-year-old girl with stage four cancer trying to get to America for clinical trial - Lancashire Telegraph - October 16th, 2021
- Stem cell & gene therapy to treat osteogenesis imperfecta: hype or hope - Open Access Government - October 5th, 2021
- Chennai-based institute to begin clinical trial on stem cell therapy for liver disease - The New Indian Express - October 5th, 2021
- "Stem cell-based therapeutics poised to become mainstream option - BSA bureau - October 5th, 2021
- Anja Health Disrupts Cord Blood Banking with Heartfelt Founding Story and Ground-Breaking Mission - Digital Journal - October 5th, 2021
- Longeveron Successfully Advancing its Cell-Based Therapy Studies in a Growing Industry Segment - Yahoo Finance - October 5th, 2021
- Ready to Treat Over 80 Life-Threatening Diseases, Discover the Potential of Cord Blood during World Cord Blood Day 2021 - PRNewswire - October 5th, 2021